CRISPR Gene Editing Enhances Immunotherapy Response in Prostate Cancer
Researchers are exploring how CRISPR gene editing could make prostate cancer more vulnerable to the body's own immune defenses. A new study shows that editing cancer cells using CRISPR technology can enhance the response to immunotherapy treatments.
The scientists targeted prostate cancer cells with CRISPR, effectively disabling mechanisms